Century Therapeutics, Inc. (IPSC) Financials

IPSC Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 360.7 million 175.9 million
2023-09-30 397.6 million 178.3 million
2023-06-30 417.2 million 169.6 million
2023-03-31 456.2 million 179.1 million

IPSC Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -27.2 million 3.6 million
2023-09-30 -16.9 million 4.0 million
2023-06-30 -23.8 million 3.3 million
2023-03-31 -34.2 million 3.8 million

IPSC Net Income

No data available :(

IPSC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 172.7 million - 48.2 million
2023-09-30 169.5 million - 45.5 million
2023-06-30 156.4 million - 42.0 million
2023-03-31 251.5 million - 41.2 million

IPSC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 59.9 million
2023-09-30 59.4 million
2023-06-30 59.3 million
2023-03-31 58.6 million

IPSC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 980000 22.3 million 8.6 million 3.6 million
2023-09-30 3.3 million 22.8 million 9.0 million -
2023-06-30 4.5 million 22.7 million 8.2 million -
2023-03-31 5.0 million 24.9 million 8.9 million -

IPSC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 268000 3.6 million
2023-09-30 148000 1.8 million
2023-06-30 99000 2.4 million
2023-03-31 1.7 million 2.2 million

IPSC

Price: $2.88

52 week price:
1.28
5.51

Earnings Per Share: -2.30 USD

P/E Ratio: -1.95

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 69234

Market Capitalization: 245.0 million

Links: